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http://dx.doi.org/10.1016/j.jmii.2013Background: Diseases caused by infectious and inflammatory microorganisms are among the
most common and most severe nosocomial diseases worldwide. Therefore, developing effec-
tive agents for treating these illnesses is critical. In this study, essential oils from two tea tree
species, kanuka (Kunzea ericoides) and manuka (Leptospermum scoparium), were evaluated
for use in treating diseases and inflammation caused by microorganism infection.
Methods: Isolates of clinically common bacteria and fungi were obtained from American Type
Culture Collection and from Kaohsiung Veterans General Hospital. Minimum inhibitory concen-
trations for Trichosporon mucoides, Malassezia furfur, Candida albicans, and Candida tropica-
lis were determined by the broth microdilution method with Sabouraud dextrose broth. Thet of Marine Biotechnology and Resources, National Sun Yat-sen University, 70 Lien-Hai Road,
t of Fragrance and Cosmetic Science, Kaohsiung Medical University, 100 Shiquan First Road,
.edu.tw (Z.-H. Wen), davidw@kmu.edu.tw (H.-M. David Wang).
an Society of Microbiology. Published by Elsevier Taiwan LLC. This is an open access article under the
commons.org/licenses/by-nc-nd/4.0/).
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Anti-infection properties of tea tree oils 105antibacterial susceptibility of Staphylococcus aureus, Streptococcus sobrinus, Streptococcus
mutans, and Escherichia coli were determined by the broth microdilution method. A human
acute monocytic leukemia cell line (THP-1) was cultured to test the effects of the essential
oils on the release of the two inflammatory cytokines, tumor necrosis factor-a and inter-
leukin-4.
Results: Multiple analyses of microorganism growth confirmed that both essential oils signifi-
cantly inhibited four fungi and the four bacteria. The potent fungicidal properties of the oils
were confirmed by minimum inhibitory concentrations ranging from 0.78% to 3.13%. The oils
also showed excellent bactericidal qualities with 100% inhibition of the examined bacteria.
In THP-1 cells, both oils lowered tumor necrosis factor-a released after lipopolysaccharide
stimulation. Finally, the antimicrobial and anti-inflammatory effects of the oils were obtained
without adversely affecting the immune system.
Conclusion: These results indicate that the potent antimicroorganism and anti-inflammation
properties of kanuka and manuka essential oils make them strong candidates for use in treating
infections and immune-related disease. The data confirm the potential use of kanuka and man-
uka extracts as pharmaceutical antibiotics, medical cosmetology agents, and food supple-
ments.
Copyright ª 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Kanuka (Kunzea ericoides) and manuka (Leptospermum
scoparium) tea trees are small trees or shrubs distributed
throughout New Zealand in widely varying climates, alti-
tudes, and population densities. Early New Zealand records
report the use of the bark, leaves, sap, and seed capsules of
these plants in beverage supplements and in pharmaceutical
and medicinal preparations.1 Kanuka and manuka are
commonly known as “tea trees” because many early New
Zealand settlers made tea from the leaves.2 Accumulating
evidenceof theuniquebiofunctional activities andmedicinal
properties of these oils has recently generated renewed in-
terest in their potential commercial applications.3 Tradi-
tional medical applications of the white leaf gums of kanuka
and manuka include internal or external sedatives, fever
reducers, and cough suppressants. A decoction of the seed
capsules canalso beused to treat inflammation. A liquid form
of the decoction alleviates dysentery, diarrhea, and colic
pain. The capsules or leaves could also be chewed to relieve
dysentery.4 A decoction formed by boiling the leaves and
bark has proven effective for treating breast inflammation,
back stiffness, and eye problems. A poultice formed from
pounded capsules of the plants was used to dry open wounds
or running sores and to treat scald and burn injuries. Finally,
the liquid could be used as a mouthwash or gargle to treat
mouth and throat sores.1
A troubling global public health issue that has emerged
in recent decades is hospital-acquired infections or non-
socomial illnesses caused by microorganisms.5 Pathogenic
fungi and bacteria are able to survive for extended periods
on human superficial skin, mucosa, or environmental sur-
faces, and have been implicated in infectious outbreaks in
hospitals, medical facilities, and institutions in many
countries.6,7 As the use of broad-spectrum antibiotics in-
creases, the most alarming characteristic of these micro-
organisms is their apparent resistance to almost all
commercially available antimicrobial drugs. As a result,
many of these microorganisms are now classified as highlyantibiotic-resistant.3,8 Therefore, the search for new
therapeutic modalities has increased requirements in nat-
ural medicinal therapy. Malassezia furfur is a lipophilic
yeast that lives on the normal skin flora of many animals,
including humans. Because the growth of this fungus re-
quires a fat source, it is most common in areas with many
sebaceous glands, including the scalp, face, and upper
body. Opportunistic infections involving some species of M.
furfur may cause hypopigmentation in the trunk and other
locations in humans.9 Trichosporon mucoides is usually
found in soil and water. Although it can contaminate human
skin, its effects in otherwise healthy individuals are usually
either harmless or are limited to superficial skin and nail
infections. In immunocompromised patients or in patients
currently undergoing immunosuppressive therapy, howev-
er, an opportunistic infection with Trichosporon can be
lethal.10 Another genus of yeast is Candida, in which the
Candida albicans and Candida tropicalis species are com-
mon and easily recognized medical yeast pathogens
because they are normal constituents of the human
flora.11,12 The most common species of Staphylococcus is
Staphylococcus aureus, which causes staphylococcal in-
fections and is frequently found in the human respiratory
tract and on skin surfaces. The emergence of antibiotic-
resistant forms of pathogenic S. aureus (e.g., methicillin-
resistant S. aureus) is a worldwide problem in clinical
medicine.13 Another species in the Streptococcus genus is
Streptococcus sobrinus, which is a spherically-shaped
anaerobic and Gram-positive bacterium. They grow in
pairs or chains, and they are not motile and do not form
spores. Streptococcus mutans is a facultatively anaerobic,
Gram-positive, coccus-shaped bacterium commonly found
in the human oral cavity and is a significant contributor to
tooth decay. The most intensively studied prokaryotic
model organism is Escherichia coli, a Gram-negative, rod-
shaped bacterium commonly found in the lower intestine of
warm-blooded organisms. This bacterium is easily and
inexpensively grown in a laboratory setting and has been
studied intensively in the past half century.14
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nism for protecting the biochemistry of an organism against
sickness, including viruses, microorganisms, worms, al-
lergies, inflammation, and cancer. An important component
of the immune system is the T-helper (Th) cell, which ini-
tiates and regulates immune responses.15,16 The four major
subtypes of Th cells in humans are: Th1, which regulates
inflammatory responses to infections; Th2, which modu-
lates allergic responses; T regulatory cells, which have a
pivotal role in immune suppression; and Th17, which is
associated with autoimmunity. The inflammatory responses
of Th1 are mainly triggered by cytokines from monocytes/
macrophages. When monocytes polarize to macrophages,
cells recognize parasitical antigens and secrete proin-
flammatory cytokines such as tumor necrosis factor-a (TNF-
a) and interleukins (ILs).17 TNF-a and IL-6 released from
monocytes/macrophages then encounter and activate
antigen-specific natural killer T cells in a process known as
the Th1 response. By contrast, in response to allergen
exposure, macrophages alternatively secrete Th2 cyto-
kines, such as IL-4, and activate Th2-mediated allergic
responses.18e20 Given the negative feedback between Th1
and Th2 (i.e., activation of one inactivates the other), an
anti-inflammatory agent might also exhibit an increased but
parallel allergic effect.21 Lipopolysaccharide (LPS) from
bacteria is a model compound with a well-known role in
inflammatory effectiveness, whereas TNF-a initiates Th1-
mediated inflammatory responses, and IL-4 inhibits in-
flammatory responses and initiates allergic responses. This
study detected both of these major cytokines, TNF-a and
IL-4, which were generated by a macrophage cell line,
human acute monocytic leukemia cell line (THP-1).
The antimicrobial and anti-inflammatory characteristics
of plant extracts have been studied and applied for thou-
sands of years.19,22 The use of plant-derived constitutes as
preservatives, cosmetics, and pharmaceuticals have
recently attracted increased interest. The present work
analyzed two essential oil extracts to identify their anti-
microbial activities in four fungi and four bacteria. The
releases of inflammatory factors TNF-a and IL-4 in THP-1
cells were also examined. The potent anti-microbial and
anti-inflammatory properties observed in these oils confirm
their strong potential use as medicinal pharmaceuticals.
Materials and methods
Reagents and oil samples
Dimethyl sulfoxide (DMSO) and LuriaeBertani broth were
purchased from Sigma-Aldrich Chemical Inc. (St Louis, MO,
USA). Sabouraud dextrose (SD) agar and SD broth were
purchased from Creative Media Products, Ltd. (Wugu
Shiang, Taiwan, R.O.C.). Dulbecco modified Eagle’s me-
dium, fetal bovine serum, penicillin, and streptomycin
were purchased from Life Technologies Co., Ltd. (Gibco,
Grand Island, NY, USA). XTT [2,3-bis-(2-methoxy-4-nitro-5-
sulfophenyl)-2H-tetrazolium-5-carboxanilide] assay kit was
purchased from Roche Diagnostics (Mannheim, Germany).
Kanuka and manuka essential oils (100%) were provided by a
local company (YO-HOON Trading Co, Ltd, Kaohsiung,
Taiwan). Both essential oils were extracted from the leavesof plants by steam distillation. All buffers and other re-
agents were of the highest purity commercially available.
Bacterial and fungal species
Six microorganism strains used in this study were purchased
from American Type Culture Collection (ATCC), included T.
mucoides (ATCC 204094), C. tropicalis (ATCC 9968), S.
aureus (ATCC 29213), S. mutans (ATCC 25175), S. sobrinus
(ATCC 33478), and E. coli (ATCC 35218). Clinical isolates of
other microorganisms, M. furfur and C. albicans, were
provided by Kaohsiung Veterans General Hospital, a 1400-
bed tertiary referral medical center in Taiwan. The THP-1
cell line used in this study, which was purchased from
ATCC (TIB-202), was derived from the peripheral blood of a
1-year-old human male with acute monocytic leukemia.
Miniaturized broth dilution susceptibility test of
anti-fungal activity
The SD broth was used to examine the susceptibilities of
the minimum inhibitory concentration (MIC) of kanuka and
manuka essential oils by the microdilution method in sterile
96-well microtiter plates covered with lids. For analyzing
oils, this method provides better reproducibility compared
to the agar plate diffusion and dilution techniques used to
study fungi.5,20,22,23 The MIC values of each strain were
determined by dissolving the testing samples in DMSO at
various concentrations with two-fold serial dilutions in
broth. DMSO was used as a blank vehicle control solvent,
and untreated microorganisms were used as negative con-
trols. To ensure that DMSO did not affect the assays, DMSO
concentrations used in the experiment were 5% lower than
those in controls. Comparisons showed no significant dif-
ference between samples with and without DMSO.
Briefly, after incubation at 35C for 2e7 days, M. furfur,
T. mucoides, C. tropicalis, and C. albicans colonies from the
SD agar plates were mixed with sterile water and then uni-
formly rotated. The fungal suspension was adjusted to an
approximate turbidity of 1  106e5  106 CFU/mL
(0.5 McFarland suspension, VITEK Special DR100 Colorimeter
52-1210; Hach Company, Loveland, CO, USA). Varying fold
dilutions of the fungal suspension in sterile water
(1  104e5  104 CFU/mL) were then added to 0.05 ml SD
broth. After adding 0.01 mL of fungal solution to each well of
a 96-well microtiter plate, the final fungi concentrations
were 1  102e5  102 CFU/well. Addition of 0.05 mL kanuka
ormanukaessential oil then obtained concentrations ranging
from 0.01% to 12.5%. After incubation in darkness for 2e7
days at 35C, the MIC values of the two oils were established
for each of the four fungi.24 All experiments were performed
in triplicate with the blank vehicle control, negative control,
and experimental control groups.
Determination of antibacterial properties
The antimicrobial properties of the kanuka and manuka
essential oils were investigated using previously described
methods.5,13 Briefly, 105 CFU/mL microbial suspensions of
four bacteria, S. aureus, S. mutans, S. sobrinus, and E. coli,
were incubated in each well at 37C for 24 hours. The
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and adjusted to McFarland 0.5 (1.5  108 CFU/mL). One
milliliter of each bacterial sample suspension was centri-
fuged at 470g for 5 minutes and then treated with 0.3 mL of
an essential oil to obtain a final concentration of 10% v/v.
Reactions were then compared at 25C at intervals of 5
seconds, 30 seconds, 60 seconds, 180 seconds, 300 seconds,
and 900 seconds. A well containing DMSO was used as the
growth blank vehicle control; a well containing medium
only was used as the negative control; and all the other
wells contained the experimental groups treated with
essential oils. A test was considered valid if the well for the
growth control group was positive and those for other
groups were negative. After the specified reaction times,
the bacteria were centrifuged for 2 minutes, washed once,
and then suspended in sterile saline water. A 104-fold
dilution of the bacterial suspension (100 mL), was then
plated on blood agar plates. After a 24-hour incubation
period, the bactericidal effects of the essential oils were
determined in each sample by measuring bacterial growth
in culture.21 The inhibition of bacterial growth was then
measured by comparison with normal growth observed in
microbes not treated with the samples.Table 1 The minimum inhibitory concentration levels of
the essential oils to four fungal species. The measured
values (% v/v solution) obtained by visual inspection of
in vitro inhibiting effects of kanuka and manuka essential
oils on fungal growth (n Z 3)
Minimum inhibitory concentration (%)








1.56 1.56 3.13 3.13XTT cell viability assay and the inflammation
evaluation
The THP-1 cells were grown in Dulbecco modified Eagle’s
medium with 10% fetal bovine serum, 100 U/mL penicillin,
and 100 mg/mL streptomycin and maintained in 75 cm2
culture dishes at 37C in a humidified chamber with 5% CO2
in air. The cells were routinely passed at a ratio of 1:2 at
least every 4 days until the day of experiment as described
previously.13 On the day prior to the experiment, all cells
were washed, and all culture media were replenished.
Immune responses produced by treatments with kanuka
and manuka essential oils were then detected. The
commercially available XTT cell proliferation assay kit
(Roche Diagnostics) was used according to the manufac-
turer instructions. The THP-1 cells were seeded into 96-well
plates (2  105 cells/mL) with or without kanuka/manuka
oil treatments with 0%, 0.1%, 0.5%, 1%, 5%, and 10%
essential oils. After 48 hours, XTT reagents were added into
each well, and colorimetric formazan products were
generated by incubation at 37C for 4 hours. Absorbance of
formazan product was measured at a wavelength of 450 nm
with a reference wavelength of 630 nm. Results are
expressed as relative cell viability normalized with un-
treated control.
The THP-1 human monocyte/macrophage cell line is
widely used to assess immune regulation, and several cell-
type-specific activation cytokines in THP-1 have been
identified. Specifically, this study selected TNF-a and IL-4
as monocyte/macrophage triggering cytokine markers.
LPS (0.2 mg/mL) was used as the positive control for
measuring inflammation, and selected target cytokines
were analyzed with commercially available enzyme-linked
immunosorbent assay kits (Quantikine; R&D System,
Minneapolis, MN, USA) according to manufacturer in-
structions. After 48 hours of essential oil treatments,
cultured THP-1 cells were centrifuged at 1000g for 10minutes to obtain cell-free supernatants for use in
measuring cytokine secretion.13
Statistical analysis
The data are expressed as the mean of values obtained in
three experiments. Statistical comparisons were performed
by Student t test for paired values.
Results
Comparisons of antifungal properties of essential
oils
As described above, the literature shows growing evidence
of the antimicrobial activities of natural products.5 Kanuka
and manuka extracts are known to kill various human
pathogens, including oral and gastrointestinal patho-
gens.25,26 The fungicidal assay in this study analyzed kanuka
and manuka essential oils extracted from New Zealand tea
trees. A broth micro-dilution assay was used to measure MIC
values and to investigate the effects of the oils in terms of
increased or decreased fungal growth. Table 1 demon-
strates the assay results for the various concentrations of
oils used in the experiment (0.01%, 0.02%, 0.05%, 0.1%,
0.2%, 0.39%, 0.78%, 1.56%, 3.13%, 6.25%, and 12.5%). The
most potent effects of kanuka essential oil were observed
in M. furfur and T. mucoides (MIC Z 0.78%). In terms of
inhibiting effects on fungal growth, kanuka oil was superior
to manuka oil (MICZ 1.56%). Additionally, the MIC values of
these two strains were two- to four-fold higher than those
observed in the analyses of Candida species. Although tests
of the other two strains showed higher MIC values, fungal
growth was still suppressed.
Antibacterial effects of essential oils
The next experiment compared the antibacterial effects of
the kanuka and manuka essential oils. At low concentration
(10%), both oils were highly effective for inhibiting the
growth of S. aureus, S. mutans, S. sobrinus, and E. coli. The
antibacterial assay also illustrated that both essential oils
effectively inhibited both Gram-negative and Gram-
108 C.-C. Chen et al.positive bacteria. Specifically, for each microbe, whether
Gram-negative or Gram-positive, growth was 100% inhibited
by exposures of 5 seconds, 30 seconds, 60 seconds, 180
seconds, 300 seconds, and 900 seconds. The antibacterial
effects of the oils still remained potent after long incuba-
tion times (data not shown). The data confirm that, in
addition to their suppressive effects on bacterial growth,
both oils have strong inhibiting effects. Additionally, the
remarkable biofunctions of the kanuka and manuka tea tree
oil samples analyzed within this study included both anti-
fungal and antibacterial activities.
Anti-inflammatory properties of kanuka and
manuka essential oils
After confirming the antimicrobial effects of kanuka and
manuka essential oils, this study further investigated other
effects such as suppression or inhibition of inflammatory
reactions. Fig. 1 demonstrates that, after 48-hour exposure
to test concentrations of kanuka and manuka essential oils
ranging from 0.1% to 10%, the viabilities of THP-1 cells
exceeded 100%. This reveals that the oils have no major
toxic side effects on THP-1 cells. In the absence of LPS
stimulation, 48-hour treatments with kanuka essential oil(A)
(B)
Figure 1. XTT assay results for THP-1 cells after 48 hours
treatment with 0%, 0.1%, 0.5%, 1%, 5%, and 10% (A) kanuka and
(B) manuka essential oils with dark green color, respectively;
LPS (0.2 mg/mL) was used as the positive control for measuring
inflammation reactions. *p < 0.05 versus untreated vehicle
control group; mean  standard deviation.
LPS Z lipopolysaccharide; XTT Z 2,3-bis-(2-methoxy-
4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide; THP-
1 Z human acute monocytic leukemia cell line.concentrations ranging from 0.1% to 10% did not signifi-
cantly change the release of cytokines, TNF-a, or IL-4 from
cultured THP-1 cells (Fig. 2). The bacterial endotoxin LPS
(0.2 mg/mL) elicits a strong inflammatory response in THP-1
cells. Cotreatment with LPS and 0.1e10% kanuka oil during
cell culture was performed to display the effects on THP-1
cytokine secretion. Kanuka essential oil treatment signifi-
cantly reduced the LPS-induced TNF-a release from THP-1
cells, but did not affect IL-4. Similarly, manuka essential
oil treatment had an anti-inflammatory effect on LPS-
induced release of TNF-a, but with no influence on IL-4
(Fig. 3).
Discussion
Although some essential oils such as tea tree oils are known
to have antimicrobial effects, clinical evidence of their
efficacy for treating bacterial, fungal, or viral infections is
limited. Kanuka is a large tree or shrub abundant
throughout New Zealand and manuka is distinguishable by
its relatively larger leaves and flowers, but smaller overallFigure 2. Enzyme-linked immunosorbent assay results for
tumor necrosis factor (TNF-a) cytokine released from THP-1
cells after stimulation with LPS (20 mg/mL) and 48 hours
treatment with 0%, 0.1%, 0.5%, 1%, 5%, and 10% (A) kanuka and
(B) manuka essential oils; **p < 0.05 versus untreated vehicle
control group; *p < 0.05 versus group treated with 0.1e10% of
the two oils after LPS incubation; mean  standard deviation.
LPS Z lipopolysaccharide; THP-1 Z human acute monocytic
leukemia cell line.
Figure 3. Enzyme-linked immunosorbent assay results for
IL-4 cytokines released from THP-1 cells after stimulation with
LPS (20 mg/mL) and 48 hours treatment with 0%, 0.1%, 0.5%,
1%, 5%, and 10% of (A) kanuka and (B) manuka essential oils
versus untreated control samples. IL Z interleukin; THP-
1 Z human acute monocytic leukemia cell line.
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both plants in traditional medicinal preparations.1,27
Maddocks-Jennings et al27 reported verification suggesting
that a gargle or mouthwash containing the essential oils of
kanuka and manuka extracts could delay the development
of mucositis and reduce associated health problems. Ac-
cording to these lecture reports, both essential oils were
with low irritations to human skin, functions on improve
oral infection, benefits in ease-breath, and help in cooling
down user’s body.1,28 Commercial applications of tea tree
essential oils for their antimicrobial and antifungal prop-
erties are in soaps, creams, mouthwashes, toothpastes, and
other preparations. Internal and external use of these oils
by herbalists and aroma therapists has as well increased in
the past twenty years.4,11
The recent emergence of new strains of bacteria and
fungi warrants intensive study of therapeutic agents for
their control and eradication.29,30 Due to the widespread
use of tea tree oils for body massage and aromatherapy,
in vivo studies have been performed to investigate their
pharmacological and antimicrobial activities in guinea pig
ileum, rat uterus, rat skeletal muscle, chick biventer
muscle, and rat phrenic nerve diaphragm.4 Studies of
manuka honey produced by New Zealand tea treessuggested that, whereas the antibacterial properties of
honey products are derived from hydrogen peroxide, those
of manuka oil are derived through other mechanisms.31,32
Our data indicate that both oils might possess various
properties to inhibit microorganism growth. Unique manuka
factor is currently the global standard for identifying and
measuring the antibacterial strength of manuka in specific
strains of bacteria.11 The antibacterial activity of manuka
honey is now standardized in terms of phenol concentration
equivalent, which is expressed as a unique manuka factor
value.30,33 However, further studies are needed to identify
the antimicroorganism mechanisms of these two target
essential oils.
Our data specify that neither oil treatment had stimu-
latory effects on cytokine release in untreated THP-1
macrophages. Interestingly, both oils showed strong inhib-
iting effects on inflammation induced by LPS treatment.
Because TNF-a release from monocytes/macrophages reg-
ulates Th1-mediated inflammatory responses, short-term
nontoxic dosages of the two essential oils may be effective
for treating inflammation. For example, the oils may be
effective for treating lesions caused by insect bites or for
repairing infectious wounds. Both essential oils reduced the
TNF-a production (Fig. 2) and did not cause cytotoxicity to
ThP-1. It is possible that essential oil may directly interact
with the toll-like receptor 4, which is an LPS receptor.
However, we did not have enough evidence for this inter-
action within the present study. We cannot rule out the
possibility for the involvement of the toll-like receptor 4
competition with essential oils, and this needs to be further
investigated in the future. Therefore, we focused on the
changes of inflammatory outcome, the TNF-a marker. The
oil treatments did not significantly affect IL-4 release,
which suggests that, in addition to the anti-inflammatory
properties, the oils have potential applications as anti-
allergic agents. Because of their anti-inflammatory prop-
erties and their absence of adverse allergic reactions
resulting from cytokine release, kanuka and manuka oils
may also be effective in human epidermal-related
products.
Aromatherapy is an alternative medicine practice in
which volatile plant materials, known as essential oils, and
other aromatic compounds are used to improve the
emotional state, cognitive function, or physical health.4
However, the literature on the efficacy of aromatherapies
for treating medical conditions, especially studies that
have applied a rigorous methodology, is very limited.
Nevertheless, some data indicate that essential oils might
have therapeutic applications.15 Essential oils are occa-
sionally used to describe fragrant oils extracted from plant
materials by any solvent-based extraction methods. Aro-
matherapists and other practitioners need to understand
that the clinical use of kanuka or manuka oils for the
varying compositions of the extracts.2 Another issue that
arises when new pharmaceutical applications of plant
components are introduced is their modulating effects
when used in combined therapy with commercial antibi-
otics or other anti-inflammatory medicines. Although some
studies have reported synergistic effects of natural plant
extracts and antibiotics when used in combined therapy,5
further study is needed to identify the efficacy of essen-
tial oils for inhibiting microbial growth and inflammation
110 C.-C. Chen et al.and particularly the chemical and taxonomic properties of
kanuka and manuka. Given the enormous potential of the
clinical applications of essential oils and the growing evi-
dence of their antimicrobial and anti-inflammatory effects,
continuing study of potential medical applications of these
and other locally produced extracts is needed. The prom-
ising findings of this study warrant further evaluation of the
current model for use in objectively measuring a contami-
nated wound environment and for assessing the mecha-
nisms of medicinal applications of kanuka and manuka oils.
However, long-term tests of the toxicity and ion-specific
effects of these oils are needed to verify their safety and
effectiveness for clinical use as wound healing agents and
for aromatherapy.Conflicts of interest
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